Eosinophilic pustular folliculitis (EPF) or Ofuji disease is a rare dermatosis, prone to recurrence and chronicity. The peak incidence occurs in the third decade of life and its exact etiology remains unknown. Evidence suggests that the expression of adhesion molecules and the production of cytokines activate the follicular unit, but the stimulus that triggers these changes remains unclear. The three clinical variants reported in the literature include classic EPF, immunosuppression-associated EPF, and infancy-associated EPF. We report a case of eosinophilic pustular folliculitis with peculiar epidemiological characteristics, which represents a challenging therapeutic scenario.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087226PMC
http://dx.doi.org/10.1590/abd1806-4841.20164778DOI Listing

Publication Analysis

Top Keywords

ofuji disease
8
disease rare
8
rare dermatosis
8
challenging therapeutic
8
eosinophilic pustular
8
pustular folliculitis
8
dermatosis challenging
4
therapeutic approach
4
approach eosinophilic
4
epf
4

Similar Publications

Erythroderma in the elderly.

J Dermatol

November 2024

Department of Dermatology, Fukushima Medical University, Fukushima, Japan.

Erythroderma is the end-stage condition caused by various inflammatory diseases, presenting with widespread generalized coalesced erythema on the trunk and extremities. Erythroderma is not a disease itself, but rather is a symptom expressing erythrodermic condition, which is frequently associated with inguinal lymphadenopathy, chills, and mild fever. The clinical characteristics include sparing the folds of the trunk and extremities (deck-chair sign), and cobblestone-like disseminated grouping prurigo; however, the deck-chair sign is not specific to papulo-erythroderma (Ofuji disease).

View Article and Find Full Text PDF
Article Synopsis
  • Eosinophilic pustular folliculitis (EPF) is a rare inflammatory skin disease mainly involving eosinophils and can appear in both follicle areas and less commonly in follicle-free areas.
  • This case study details two patients with difficult-to-treat EPF who had previous treatment failures with various standard therapies.
  • Both patients responded positively to the medication abrocitinib, achieving complete remission in one week and four weeks, with no side effects reported, suggesting it could be a safe treatment option for EPF.
View Article and Find Full Text PDF

Eosinophilic Pustular Folliculitis in the Setting of Untreated Chronic Lymphocytic Leukemia.

Cutis

March 2024

University of Pittsburgh School of Medicine, Pennsylvania. Drs. Kim and Patton are from the Department of Dermatology, and Drs. Beatty and Choudhary are from the Department of Dermatopathology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!